MXL MAXLINEAR, INC
Semiconductors & Related Devices · Nasdaq · SEC CIK 1288469 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY56.0%
TTM net income YoY83.6%
TTM EPS YoY84.2%
Revenue 3-yr CAGR-8.4%
Net income 3-yr CAGR—
Margins
Gross margin58.0%
Operating margin-0.9%
Net margin-4.4%
FCF margin-3.1%
EBITDA margin4.9%
Returns
ROE-5.9%
ROA-3.4%
ROIC (approx.)-0.9%
Asset turnover0.77x
Leverage & solvency
Liabilities / assets41.8%
Debt / equity0.31x
Current ratio2.22x
Interest coverage-0.63x
Cash quality & payout
Operating cash flow / net income0.25x
Accruals ratio-2.6%
Payout ratio—
Capex / revenue2.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $218.06M | $168.85M | $137.19M | $136.44M | $126.46M | $108.81M | $95.93M | $92.17M |
| Cost of revenue | $89.99M | $71.18M | $58.30M | $57.88M | $54.56M | $47.29M | $42.10M | $40.92M |
| Gross profit | $128.07M | $97.66M | $78.88M | $78.56M | $71.90M | $61.52M | $53.83M | $51.25M |
| R&D expense | $60.64M | $56.03M | $53.16M | $51.69M | $54.25M | $47.20M | $55.46M | $51.28M |
| SG&A expense | $36.95M | $45.75M | $42.46M | $41.96M | $47.67M | $33.36M | $36.59M | $38.09M |
| Operating income | $30.23M | -$4.18M | -$17.21M | -$14.89M | -$41.29M | -$24.61M | -$46.09M | -$41.17M |
| Interest expense | $2.69M | $2.27M | $2.20M | $2.39M | $2.65M | $2.51M | $2.50M | $2.80M |
| Pretax income | $28.17M | -$6.55M | -$18.65M | -$17.80M | -$43.39M | -$30.70M | -$49.00M | -$40.82M |
| Income tax | -$732,000 | -$8.31M | $26.48M | -$2.91M | $2.10M | -$4.12M | $711,000 | $17.02M |
| Net income | $28.90M | $1.76M | -$45.14M | -$14.90M | -$45.48M | -$26.59M | -$49.71M | -$57.84M |
| EBITDA | $35.63M | $1.42M | -$6.27M | $1.53M | -$35.59M | -$18.71M | -$34.95M | -$29.46M |
| EPS (basic) | 0.32 | 0.02 | -0.52 | — | -0.52 | -0.31 | -0.58 | — |
| EPS (diluted) | 0.30 | 0.02 | -0.52 | — | -0.52 | -0.31 | -0.58 | — |
| Weighted avg. shares (diluted) | 97.71M | 97.33M | 87.59M | — | 87.19M | 86.63M | 85.27M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $81.08M | $64.81M | $61.08M | $72.81M | $113.26M | $110.25M | $104.06M | $119.60M |
| Receivables | $73.38M | $51.04M | $40.85M | $46.12M | $52.93M | $105.82M | $98.92M | $85.46M |
| Inventory | $113.72M | $105.49M | $85.84M | $78.10M | $86.33M | $86.03M | $86.00M | $90.34M |
| Current assets | $391.19M | $298.66M | $249.45M | $248.84M | $284.13M | $330.15M | $320.41M | $323.44M |
| PP&E, net | $41.28M | $41.21M | $44.36M | $48.87M | $50.87M | $51.12M | $55.55M | $59.30M |
| Goodwill | $318.59M | $318.59M | $318.59M | $318.59M | $318.59M | $318.59M | $318.59M | $318.59M |
| Intangibles | $44.05M | $43.78M | $46.41M | $48.89M | $52.07M | $54.36M | $51.59M | $55.01M |
| Total assets | $916.43M | $822.57M | $771.27M | $796.40M | $808.13M | $863.74M | $855.28M | $864.64M |
| Current liabilities | $176.42M | $168.12M | $146.66M | $186.02M | $183.55M | $213.49M | $196.89M | $182.28M |
| Short-term debt | $0 | $0 | — | $0 | — | — | — | — |
| Long-term debt | $164.06M | $123.93M | $123.77M | $123.62M | $123.46M | $123.31M | $123.15M | $123.00M |
| Total debt | $164.06M | $123.93M | $123.77M | $123.62M | $123.46M | $123.31M | $123.15M | $123.00M |
| Total liabilities | $383.42M | $337.73M | $317.08M | $344.50M | $343.41M | $375.41M | $362.11M | $348.36M |
| Shareholders' equity | $533.01M | $484.84M | $454.19M | $451.89M | $464.73M | $488.33M | $493.18M | $516.28M |
| Net debt | $82.98M | $59.11M | $62.70M | $50.81M | $10.20M | $13.05M | $19.09M | $3.39M |
| Shares outstanding | 91.00M | 90.69M | 89.53M | 86.45M | 87.37M | 86.91M | 86.37M | 84.61M |
| Cash flow statement | ||||||||
| Operating cash flow | -$13.59M | $4.81M | -$8.87M | $10.41M | $10.12M | $10.49M | -$11.40M | -$27.84M |
| Capital expenditure | $5.94M | $2.34M | $1.38M | $3.71M | $5.73M | $1.17M | $1.99M | $2.19M |
| Free cash flow | -$19.53M | $2.47M | -$10.26M | $6.70M | $4.39M | $9.32M | -$13.39M | -$30.03M |
| Investing cash flow | -$9.65M | -$3.15M | -$4.24M | -$3.69M | -$6.74M | -$7.38M | -$1.99M | -$3.00M |
| Financing cash flow | $39.91M | $1.61M | $2.28M | -$18.61M | $15,000 | $2.08M | -$2.14M | $1.42M |
| Depreciation & amortization | $5.40M | $5.60M | $10.94M | $16.42M | $5.70M | $5.90M | $11.15M | $11.71M |
| Stock-based compensation | $19.82M | $27.48M | $20.03M | $19.59M | $21.51M | $13.11M | $22.91M | $18.81M |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.